Cardiovasculaire Geneeskunde.nl

Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation

Själander S, Sjögren V, Renlund H et al.,

22 aug. 2018

Själander S, Sjögren V, Renlund H et al., Thromb Res. 2018 May 17;167:113-118

Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation

Esteve-Pastor MA, Rivera-Caravaca JM, Roldán V et al.

22 aug. 2018

Esteve-Pastor MA, Rivera-Caravaca JM, Roldán V et al., Am J Cardiol. 2018 Jun 2

Effectiveness and Safety of Rivaroxaban Versus Warfarin in Nonvalvular Atrial fibrillation Patients with a Non-Sex-Related CHA2DS2-VASc Score of 1

Coleman CI, Turpie AGG, Bunz TJ et al., Eur Heart J Cardiovasc Pharmacother. 2018

31 juli 2018

Coleman CI, Turpie AGG, Bunz TJ et al., Eur Heart J Cardiovasc Pharmacother. 2018

Global Prospective Safety Analysis of Rivaroxaban

Kirchhof P, Radaideh G, Kim Y-H et al., J Am Coll Cardiol 2018;: 72: 2 DOI: 10.1016/j.jacc.2018.04.058

9 juli 2018

Kirchhof P, Radaideh G, Kim Y-H et al., J Am Coll Cardiol 2018; 72: 2 DOI: 10.1016/j.jacc.2018.04.058

Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation

Andersson NW, Svanström H, Lund M et al., Int J Cardiol. 2018

3 juli 2018

Andersson NW, Svanström H, Lund M et al., Int J Cardiol. 2018

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation

Martinez BK, Sood NA, Bunz TJ et al. J Am Heart Assoc. 2018

23 apr. 2018

Martinez BK, Sood NA, Bunz TJ et al. J Am Heart Assoc. 2018

Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation

Shah S, Norby FL, Datta YH et al., Blood advances 2018

4 feb. 2018

Shah S, Norby FL, Datta YH et al., Blood advances 2018

Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach

Li X, Keshishian A, Hamilton M et al., PLoS ONE 2018

30 jan. 2018

Li X, Keshishian A, Hamilton M et al., PLoS ONE 2018

Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation

Hohnloser SH, Basic E, Hohmann C et al., Thromb Haemost. 2018

22 jan. 2018

Hohnloser SH, Basic E, Hohmann C et al., Thromb Haemost. 2018

Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany

Collings S-L, Lefevre C, Johnson ME et al., PLoS ONE 2017

8 jan. 2018

Collings S-L, Lefevre C, Johnson ME et al., PLoS ONE 2017

Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients 80+ Years-of-Age with Nonvalvular Atrial Fibrillation

Coleman CI, Weeda ER, Nguyen E et al., Eur Heart J Qual Care Clin Outcomes. 2017

7 dec. 2017

Coleman CI, Weeda ER, Nguyen E et al., Eur Heart J Qual Care Clin Outcomes. 2017

Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation

Yao X, Tangri N, Gersh BJ et al., J Am Coll Cardiol. 2017

4 dec. 2017

Yao X, Tangri N, Gersh BJ et al., J Am Coll Cardiol. 2017